Telehealth support for caregivers of cancer patients
Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
This study tests if a telehealth support program can help caregivers of cancer patients feel less stressed about money and depression while improving their confidence and satisfaction in caring for their loved ones.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Trial ID | NCT06709404 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a telehealth navigation intervention aimed at assisting primary caregivers of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC). The study focuses on reducing financial distress and depression while enhancing self-efficacy, satisfaction, and engagement in care. Participants are randomized into two groups: one receiving the telehealth intervention and the other receiving standard care. The study assesses various outcomes, including financial distress, quality of life, and community resource utilization over time.
Who should consider this trial
Good fit: Ideal candidates are primary caregivers of patients scheduled for CS+HIPEC who have access to technology and can provide informed consent.
Not a fit: Patients who do not have access to a computer or smartphone, or who are unable to understand English, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly alleviate financial stress and improve the overall well-being of caregivers.
How similar studies have performed: Other studies have shown promise in using telehealth interventions to support caregivers, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center * Access to a computer or smartphone and must have an email address * 18 years of age or older at the time of consent * The ability to understand and willingness to provide written informed consent * The ability to read and write English Exclusion Criteria \- Patient declines access to their medical record
Where this trial is running
Winston-Salem, North Carolina
- Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Katie Duckworth — Wake Forest Baptist Comprehensive Cancer Center
- Study coordinator: Study Coordinator
- Email: Emily.Teal@advocatehealth.org
- Phone: 3367165772
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.